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For a comprehensive description of the tissue-specific thyroidal state under normal as well
as under pathophysiological conditions it is of utmost importance to include thyroid hor-
mone (TH) transporters in the analysis as well. The current knowledge of the cell-specific
repertoire ofTH transporters, however, is still rather limited, although severalTH transport-
ing proteins have been identified. Here, we describe the temporal and spatial distribution
pattern of the most prominent TH transporters in the postnatal mouse brain. For that pur-
pose, we performed radioactive in situ hybridization studies in order to analyze the cellular
mRNA expression pattern of the monocarboxylate transporters Mct8 and Mct10, the L-type
amino acid transporters Lat1 and Lat2 as well as the organic anion transporting peptide
Oatp1c1 at different postnatal time points. HighestTH transporter expression levels in the
CNS were observed at postnatal day 6 and 12, while hybridization signal intensities visibly
declined after the second postnatal week. The only exception was Mct10 for which the
strongest signals could be observed in white matter regions at postnatal day 21 indicat-
ing that this transporter is preferentially expressed in mature oligodendrocytes. Whereas
Mct8 and Lat2 showed an overlapping neuronal mRNA expression pattern in the cerebral
cortex, hippocampus, and in the hypothalamus, Oatp1c1 and Lat1 specific signals were
most prominent in capillary endothelial cells throughout the CNS. In the choroid plexus,
expression of three transporters (Mct8, Lat2, and Oatp1c1) could be detected, whereas
in other brain areas (e.g., striatum, thalamus, and brain stem nuclei) only one of the trans-
porter candidates appeared to be present. Overall, our study revealed a distinct mRNA
distribution pattern for each of theTH transporter candidates. Further studies will reveal to
which extent these transporters contribute to the cell-specific TH uptake and efflux in the
mouse CNS.
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INTRODUCTION
Thyroid hormone (TH) action requires the presence of TH trans-
porters that facilitate its cellular uptake and efflux (1–4). Since
TH metabolizing deiodinases as well as TH receptors are intracel-
lularly active, TH transporter deficiency can greatly compromise
tissue TH homeostasis. As the most prominent example, inacti-
vating mutations in the monocarboxylate transporter 8 (MCT8;
SCL16A2) gene, which encodes a very specific TH transporter (5),
result in an abnormal serum TH profile with highly elevated lev-
els of the receptor active hormone T3 (3,3′,5,-triiodothyronine)
and low T4 concentrations of the prohormone T4 (3,3′,5,5′-
tetraiodothyronine) (6–8). Moreover, patients with MCT8 muta-
tions suffer from a severe form of psychomotor retardation sug-
gesting that in the absence of MCT8, neural differentiation and
function is severely impaired possibly due to insufficient TH sup-
ply during critical stages of development (9). The exact role of
MCT8 is still enigmatic since only limited information is cur-
rently available concerning the cellular localization of MCT8 in
the developing and adult human CNS (10–12).
Studies of Mct8 knockout (ko) mice unequivocally revealed that
Mct8 is not the only protein involved in TH transport processes
in the murine CNS (11, 13, 14). Although immunohistochemi-
cal studies and in situ hybridization (ISH) experiments showed
pronounced Mct8 expression in distinct neuronal populations of
the cerebral cortex, hippocampus, striatum, hypothalamus, and
cerebellum (15), Mct8 ko mice do not display overt neurological
symptoms (11), although they faithfully replicate the abnormal
serum TH parameters characteristic for human MCT8 deficiency.
These Mct8 ko mice also do not show immunohistochemically any
abnormalities such as a delayed Purkinje cell development or an
altered differentiation of inhibitory neurons in the cerebral cor-
tex, both strong neuronal indicators for TH deprivation (11, 14).
Based on these observations, it was hypothesized that other TH
transporting proteins can compensate for the absence of Mct8 in
the mouse CNS. Indeed, analysis of primary neuronal cultures
from the mouse cortex revealed a collaborative action of Mct8 and
the L-type amino acid transporter Lat2 that in addition to large
neutral amino acids also accepts TH as substrates (11). Which
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transporters, however, are co-expressed with Mct8 in vivo has not
been sufficiently addressed yet.
Apart from neurons, Mct8 is present in capillary endothelial
cells as well as in the choroid plexus structures, thus in cells that
build up the blood–brain (BBB) and the blood–cerebrospinal
fluid-barrier (BCSFB), respectively (10, 11, 15). That Mct8 is
indeed involved in the passage of TH via the BBB and/or BCSFB
could be demonstrated by in vivo transport studies. Uptake of T3
from the circulation into the CNS was strongly diminished in Mct8
ko mice, whereas the transport of T4 was only mildly compromised
(14, 16) due to the presence of the T4 transporting organic anion
transporting peptide Oatp1c1 (Slco1c1) (17–19). Indeed, the gen-
eration and analysis of Mct8/Oatp1c1 double knockout (dko) mice
confirmed the physiological significance of both TH transporters
for proper TH homeostasis in the murine brain since the brain T3
and T4 content of these animals was reduced to 10% of wild-type
levels (20). Obviously, Mct8 and Oatp1c1 act as a pair in medi-
ating TH access to the CNS, although the residual TH amounts
found in brain homogenates of Mct8/Oatp1c1 dko mice suggest
that additional, not yet identified TH transporters contribute to
this process as well.
From all these mouse studies it became strikingly clear that a
detailed determination of the tissue- and cell-specific repertoire
of TH transporters is highly needed for a comprehensive under-
standing of TH trafficking, metabolism, and action under normal
as well as pathological conditions. Recently, Braun et al. generated
a developmental profile of TH transporter expression patterns in
different brain regions by performing western blot analysis and
qPCR studies (21). However, these studies did not provide any
information regarding the cellular localization pattern. We there-
fore conducted a series of ISH experiments that allow the temporal
and spatial analysis of TH transporter expression with a cellu-
lar resolution in the postnatal mouse brain. In addition to Mct8,
Oatp1c1, and Lat2, we included the aromatic amino acid trans-
porter Mct10 (Slc16a10) and the L-type amino acid transporter
Lat1 (Slc7a5) in our study since both proteins have been shown to
accept TH as substrates (22, 23) and may play an important role
for TH transmembrane passage in the CNS as well.
MATERIALS AND METHODS
ANIMALS
All mice were provided with standard laboratory chow and tap
water ad libitum and were kept at constant temperature (22°C) and
controlled light cycle (12 h light, 12 h dark). Male wild-type mice
were killed in accordance with local regulations (TLLV Thürin-
gen, Erfurt, Germany; approval number TöA-FLI149-08) by CO2
at different postnatal time points (P6, P12, P21, P84) and brains
were frozen in isopentane cooled on dry ice. For each time point,
three brains were prepared. Coronal cryosections with a thickness
of 20µm were cut with a cryostat and thaw mounted on super-
frost slides (Thermo Scientific). Slides were stored at−80°C until
further processing.
IN SITU HYBRIDIZATION HISTOCHEMISTRY
A cDNA fragment corresponding to nt 1251–1876 of mouse
Mct8 (GenBank accession number AF045692), nt 911–1663 of
mouse Mct10 (NM_001114332), nt 921–1357 of mouse Lat1
(NM_011404.3), nt 972–1457 of mouse Lat2 (NM-016972.2), nt
360–470 of mouse Oatp1c1 (NM_021471.1) were generated by
PCR and subcloned into the pGEM-T Easy Vector (Promega).
Radiolabeled riboprobes were generated by in vitro transcrip-
tion using 35S-UTP as labeled substrate (Hartmann Analytik,
Braunschweig, Germany). ISH was carried out as published else-
where (24). In brief, frozen sections were air-dried, followed by
an 1-h fixation in a 4% phosphate-buffered paraformaldehyde
(PFA) solution (pH 7.4) and then permeabilized by incubation
in 0.4% Triton-X 100/PBS for 10 min. Acetylation was carried
out in 0.1 M triethanolamine (pH 8.0) containing 0.25% (v/v)
acetic anhydride. Sections were dehydrated and then covered with
hybridization mix containing cRNA probes diluted in hybridiza-
tion buffer (50% formamide, 10% dextran sulfate, 0.6 M NaCl,
10 mM Tris–HCl pH 7.5, 1×Denhardt’s solution, 100µg/ml son-
icated salmon sperm DNA, 1 mM EDTA, and 0.5 mg/ml t-RNA).
35S-labeled riboprobes were diluted in hybridization buffer to a
final concentration of 1× 104 cpm/µl (Mct8) or 2× 104 cpm/µl
(Lat1, Lat2, Oatp1c1). Hybridization was performed over night at
58°C. Slides were rinsed in 2× standard saline citrate (0.3 M NaCl
and 0.03 M sodium citrate, pH 7.0) and subsequently treated with
ribonuclease A/T1 at 37°C for 30 min. Final washes were carried
out in 0.2× standard saline citrate at 65°C for 1 h. For detecting
radioactive hybridization signals, the sections were dehydrated and
then exposed to x-ray film (BioMax MR, Eastman Kodak Co.) for
24–48 h. Thereafter, sections were dipped in Kodak NTB nuclear
emulsion (Kodak) and stored at 4°C for 8 days (Mct8), 7 days
(Lat1), 6 days (Lat2), or 11 days (Oatp1c1). Autoradiograms were
developed and analyzed under dark-field illumination. As con-
trols, consecutive brain sections were probed with the sense-strand
probes of the same size and specific activity and processed in the
same manner as the sections covered with the respective antisense
probe. For none of these sense probes has a positive signal been
encountered.
RESULTS
The aim of the current study was to perform a comparative analysis
of TH transporter expression patterns in the murine CNS at differ-
ent postnatal time point. In particular, we aimed to determine the
cellular distribution pattern of the transporters Mct8 (Slc16a2),
Mct10 (Slc16a10), Lat1 (Slc7a5), Lat2 (Slc7a8), and Oatp1c1
(Slco1c1) that have all been described to facilitate the cellular
transport of TH (25). Since only for a subset of these proteins spe-
cific antibodies are available, we employed a highly sensitive ISH
technique using 35S-labeled RNA probes. Brains were collected
from C57/Bl6 male mice at postnatal day 6 (P6), P12, P21, and
P84 and consecutive frozen brain sections were subjected to the
ISH procedure as described previously (24). For the description
of the mRNA distribution at a cellular resolution, nuclear emul-
sion coated slides were examined under dark-field illumination
using a light-microscope. Each antisense probe indeed produced
a positive hybridization signal with a highly distinct cellular dis-
tribution pattern as visualized exemplarily in Figures 1–4 for four
different anatomical regions. In particular, Figure 1 illustrates cor-
tical and striatal expression at around Bregma 0.50 mm; Figure 2
(between Bregma −1.8 and −2.2 mm) shows mRNA expression
patterns in the cortex,hippocampus, thalamus,and hypothalamus;
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FIGURE 1 | Illustration ofTH transporter mRNA expression in the murine
forebrain. Coronal cryosections of mouse brains collected at different
postnatal days were hybridized with radioactively labeled riboprobes specific
for Mct8 (A1–A4), Lat2 (B1–B4), Oatp1c1 (C1–C4), Lat1 (D1–D4), and Mct10
(E1–E4). Dark-field autoradiograms illustrate the mRNA expression patterns at
the level of the striatum (CPu, caudate–putamen) around Bregma 0.5 mm. VI,
layer 6 of the cerebral cortex; cc, corpus callosum; Cg, cingulate cortex, LV,
lateral ventricle; Pir, piriform cortex; SP, subplate neurons (cerebral cortex).
Figure 3 depicts TH transporter expression between Bregma−3.4
and−4.4 including mesencephalic areas; Figure 4 shows cerebellar
and brainstem expression pattern around Bregma−6.2 [according
to Franklin and Paxinos (26)].
DISTRIBUTION PATTERN OF Mct8 AND Lat2
In agreement with our previous analysis (15) and immunohis-
tochemical studies (11), Mct8 was found in different brain areas
with strongest expression levels in pyramidal and granule cells of
the hippocampus, in the choroid plexus and in tanycytes of the
third ventricle (Figures 2A1–A4). Pronounced hybridization sig-
nals were also found in the upper layers of the cerebral cortex,
throughout the striatum (Figures 1A1–A4) as well as in cere-
bellar Purkinje cells particularly during the first postnatal weeks
(Figures 4A1–A4). In these areas, Mct8 signal intensities were vis-
ibly reduced in the adult animals indicating a temporal decline
in expression. A similar trend was also observed for Lat2 that
exhibited an overlapping expression pattern with Mct8 in distinct
areas such as the choroid plexus, the hippocampus, the cerebral
cortex, and the hypothalamic neurons of the PVN (Figures 2B1–
B4). Highest mRNA expression of Lat2, however, was observed
throughout the thalamic region, an area devoid of Mct8 specific
hybridization signals (Figures 2B1–B4). Lat2 specific mRNA sig-
nals were also found in the pontine nucleus (Figures 3B1–B4),
various brain stem nuclei such as the facial nucleus, hypoglos-
sal nucleus, and the raphe nuclei (Figures 4B1–B4) where Mct8
expression could not be detected. Another example for a com-
plementary expression of Mct8 and Lat2 was observed in the
cerebellar cortex where Mct8 transcript levels could be detected
in granule precursor cells of the external granule cell layer at P6
as well as in developing Purkinje cells (at P6 and P12), whereas
Lat2 was most intensely expressed in mature granule cells of the
internal granule cell layer (Figures 4A1–A4,B1–B4). Overall, our
results indicate a co-expression of both TH transporters only in
distinct areas of the mouse CNS.
DISTRIBUTION PATTERN OF Oatp1c1 AND Lat1
Our ISH analysis confirmed published studies indicating a prefer-
ential expression of Oatp1c1 in choroid plexus structures, ventricle
ependymal cells, and capillary endothelial cells (Figures 1C1–C4
and 2C1–C4) (10, 18, 27). In addition to the elongated hybridiza-
tion signals typically for vessel structures, ISH analysis for Oatp1c1
also revealed scattered signals throughout the CNS with slightly
stronger intensities in the hippocampal formation (Figures 2C1–
C4 and 3C1–C4). Such an expression pattern points to an astroglial
localization of this transporter in line with previous findings
(28). A capillary localization could also be confirmed for Lat1.
However, in contrast to Oatp1c1, Lat1 is not expressed in the
choroid plexus. Moreover, at P6 and, to a lesser extent at P12,
Lat1 specific hybridization signals were detected in few neuronal
populations such as in pyramidal neurons of the hippocampal
CA3 region and the cerebellar granule cells indicating that dur-
ing early stages of postnatal development, Lat1 is also present in
distinct neurons (Figures 2D1–D4 and 4D1–D4). For both trans-
porters Oatp1c1 and Lat1, hybridization signal intensities were
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FIGURE 2 | mRNA distribution patterns ofTH transporters in the murine
hippocampus and diencephalon. Mct8 (A1–A4) and Lat2 (B1–B4) exhibited
an overlapping mRNA expression in the cerebral cortex, hippocampus (Hip),
amygdala (Amyg), hypothalamic paraventricular nucleus (PVN), and choroid
plexus (ChP). Mct8 but not Lat2 is highly expressed in tanycytes (Tan) lining
the third ventricle (3V). In contrast, Lat2 but not Mct8 is strongly expressed in
thalamic nuclei (Thal). Elongated hybridization signals scattered throughout
the CNS indicate a capillary localization of Oatp1c1 (C1–C4) and Lat1
(D1–D4). In addition, Lat1 is present in the hippocampal CA3 neurons at
postnatal day P6. Mct10 (E1–E4) is also temporarily expressed in
hippocampal and cortical neurons. At P21, however, highest hybridization
signal intensities are observed in white matter areas [e.g., in the cerebral
peduncle (cp) or the hippocampal fimbria (fi)]. DG, dentate gyrus; DM,
dorsomedial hypothalamic nucleus.
significantly reduced at P84 indicating an age-dependent decline
in the respective transporter expression.
DISTRIBUTION PATTERN OF Mct10
Determination of Mct10 mRNA expression in the mouse brain at
P6 and P12 revealed overall only very weak signal intensities in
specific areas such as layer 6, and subplate neurons of the cerebral
cortex as well as granule cells of the dentate gyrus and of the cere-
bellar cortex (Figures 1E1–E4 and 2E1–E4). At P21, strong signals
could be detected throughout white matter regions suggesting that
Mct10 is highly enriched in mature oligodendrocytes. In addition,
Mct10 expression was clearly visible in the adult brain in neurons
of the dentate gyrus and in distinct hypothalamic nuclei such as
the dorsomedial nucleus (Figures 2E1–E4). Overall, Mct10 mRNA
expression appeared to increase with increasing age of the animals.
DISCUSSION
Though the importance of TH transporters for proper TH action
in the developing and mature CNS has been widely acknowledged,
very limited information has been provided so far concerning the
localization of TH transporter candidates both in the human as
well as mouse CNS. In particular, the generation and analysis
of Mct8 deficient mice have raised many questions since these
animals lack any overt neurological symptoms, an unexpected
finding in light of the pronounced expression of Mct8 in neuronal
populations (15). Indeed, an area- as well as cell-type specific
analysis of the thyroidal state revealed overall only a mild T3-
deprivation such as in striatal cells (14), a normal T3-status in
cerebellar neurons (14, 16) and very subtle changes in the cerebral
cortex (29). The latter finding has been explained by the presence
of Lat2 in cortical neurons that may compensate for the absence of
Mct8 in the mouse brain (11). In support for this hypothesis, we
could observe a pronounced neuronal expression of Lat2 through-
out the cortex with highest signal intensities at P12. Mct8 and Lat2
may also co-operate in mediating TH transport in pyramidal cells
of the hippocampus and in neurons of the hypothalamic par-
aventricular nucleus where transcripts for both transporters could
be detected. Possibly, TRH expressing neurons are dependent on
Mct8 and Lat2 for a proper negative feedback regulation within
the hypothalamus–pituitary–thyroid axis. In this respect, it would
be of most interest to study the TH-sensitivity of these neurons in
Mct8/Lat2 double deficient animals.
Our analysis, however, also revealed striking differences in the
Mct8 and Lat2 distribution pattern with the striatum, thalamus,
and brain stem nuclei as the most evident examples. Based on
these observations, we assume that besides Lat2, additional pro-
teins must be present in the mouse brain that can facilitate the
transmembrane passage of TH in neurons in the absence of Mct8.
One possible candidate is Mct10 that accepts in addition to
aromatic amino acids TH as substrate as well (22). Mct10 protein
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FIGURE 3 | Differential expression ofTH transporters in midbrain regions.
Whereas Mct8 mRNA expression is close to the detection limit in the
midbrain area (A1–A4), Lat2 specific hybridization signals (B1–B4) are
observed in distinct nuclei such as the paratrochlear nucleus (Pa4) and the
pontine nuclei (Pn). Weak signals for Lat2 are also found in the superior
colliculi (Sc). Oatp1c1 (C1–C4) and Lat1 (D1–D5) exhibit a capillary expression
pattern whereas Mct10 (E1–E4) is strongly expressed in the white matter and
dentate gyrus neurons (DG). Aq, aqueduct.
was localized in neurons of the human hypothalamus (12), but
its localization in the mouse brain has not been experimentally
addressed yet. Here, we could detect Mct10 transcripts in neurons
of the hippocampus where Mct10 showed an overlapping expres-
sion with Mct8. In contrast, Mct8 and Mct10 exhibited a comple-
mentary distribution pattern in the cerebral cortex, which makes
a compensatory function of Mct10 in the absence of Mct8 rather
unlikely. Moreover, our recent characterization of Mct10/Mct8
deficient animals did not reveal a pronounced TH deficiency in
the CNS (30) indicating that at least in the developing murine
brain, Mct10 does not significantly contribute to TH transport
processes.
Intense Mct10 specific signals were found in white matter
regions of the murine CNS at P21 and P84 suggesting that this
transporter is highly expressed only in mature oligodendrocytes. It
therefore remains to be investigated, which proteins are involved in
supplying immature oligodendrocytes with TH particularly since
TH represents a critical factor for proper differentiation of these
cells (31, 32).
Previous studies of Mct8 ko mice demonstrated a critical role
of this transporter in mediating the uptake of T3 via the BBB
and/or the BCSFB (14, 16). This physiological function correlates
with a strong expression of Mct8 in choroid plexus structures,
tanycytes of the third ventricle as well as in capillary endothe-
lial cells as evidenced by immunohistochemical studies (10, 11).
Remarkably, Mct8 mRNA expression could only be detected by
ISH in larger vessels while choroid plexus structures and tanycytes
displayed strong Mct8 mRNA specific signals. The reason for the
discrepancy between transcript and protein levels in capillary Mct8
expression cannot be solely related to possible limitations of the
ISH procedure since smaller capillaries throughout the brains
were successfully visualized with radioactive Oatp1c1 and Lat1
specific RNA probes. It therefore needs to be further assessed in
a cell-specific manner how Mct8 expression is regulated on the
transcriptional as well as on the translational level.
While in mice, inactivation of Oatp1c1 alone had only mild
consequences on the thyroid state of the CNS (27), Mct8/Oatp1c1
dko mice displayed a highly diminished transport of T4 and T3
into the CNS, a finding that underscores the concerted function
of Mct8 and Oatp1c1 in facilitating the brain entry of TH via the
BBB and/or BCSF (20). Moreover, brain TH concentrations in
Mct8/Oatp1c1 were reduced to 10% of the respective wild-type
levels indicating a robust hypothyroid state in the CNS. However,
it is currently unclear by which pathway the residual TH enters
the brain in these animals. In this process, Lat1 may possibly be
involved as our ISH analysis revealed a preferential expression of
this transporter in capillary cells as well. The exact physiological
contribution of Lat1 for TH traffic in the brain will only been
unraveled following the generation and analysis of the respective
mouse mutants that are either deficient in Lat1 alone or lack even
all three TH transporters.
In summary, our ISH analysis revealed a distinct and unique
temporal and spatial mRNA expression pattern for all five TH
transporter candidates in the murine brain. Although we cannot
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FIGURE 4 | Cerebellar and brainstem expression pattern ofTH
transporters. In the developing cerebellum, Mct8 specific hybridization
signals can be found in the external granule cell layer (EGL) and the Purkinje
cell layer (PCL) (A1,A2) whereas after weaning Mct8 mRNA expression is
largely restricted to choroid plexus structures of the fourth ventricle (4V)
(A3,A4). In comparison, Lat2 mRNA levels are high in the internal granule cell
layer (IGL) indicating that mature granule cells express this transporter
(B1–B4). Lat2 specific signals could also be found in various brainstem nuclei
such as the facial nucleus (7), the raphe obscurus nucleus (ROb), the spinal 5
nucleus (Sp5), and the spinal vestibular nucleus (SpVe). Oatp1c1 is highly
expressed in choroid plexus as well as in endothelial cells (C1–C4) where also
Lat1 staining can be observed. In addition, Lat1 expression is found in the EGL
and PCL of the cerebellar cortex at P6 (D1–D4). Mct10 expression pattern
indicates a pronounced localization in mature oligodendrocytes (E1–E4).
provide any information about the respective protein levels and
subcellular localization, our study will provide a solid ground for
determining the cell-specific function of these transporters by tak-
ing advantage of conditional mouse mutants. Our data, however,
also disclosed that additional TH transporter proteins need to
be discovered in order to fully understand TH traffic in such a
complex and important TH target organ as the CNS.
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